Yttrium-90 Conjugated to Humanized Monoclonal Antibody 3S193
N/A
Report date: 2025/10/20 14:38:41
Base Information
Drug NameYttrium-90 Conjugated to Humanized Monoclonal Antibody 3S193
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesLudwig Institute For Cancer ResearchNational Cancer Institute
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A